---
title: "Tejnaksh Healthcare Ltd (539428) — Share Price, Financials & Analysis"
symbol: "539428"
company: "Tejnaksh Healthcare Ltd"
canonical: "https://tapetide.com/stocks/539428"
isin: "INE030T01027"
nse_symbol: "TEJNAKSHHEALTHCARELTD"
bse_code: "539428"
sector: "Healthcare Services"
industry: "Healthcare Service Provider"
market_cap_cr: 27.39
generated_at: "2026-09-13T19:44:33.037Z"
---

# Tejnaksh Healthcare Ltd (539428)

Canonical page: https://tapetide.com/stocks/539428

## Company

- **NSE Symbol:** TEJNAKSHHEALTHCARELTD
- **BSE Code:** 539428
- **ISIN:** INE030T01027
- **Sector:** Healthcare Services
- **Industry:** Healthcare Service Provider
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2015-10-27
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** tejnaksh.com

## About

Incorporated in 2008, Tejnaksh Healthcare 
Ltd is in the business of Healthcare Services 
and Pharmacies[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:41:32.796633Z.

- **Market Cap:** ₹27.39 Cr
- **Classification:** Microcap
- **P/E (reported):** 21.7
- **EPS (TTM):** ₹0.61
- **EPS (reported):** ₹0.87
- **Book Value:** ₹13.36
- **Price to Book:** 0.99
- **Dividend Yield:** 0%
- **ROE:** 8.43%
- **ROCE:** 12.21%
- **Debt to Equity:** 0.01
- **Revenue (yearly):** ₹10.79 Cr
- **Net Income:** ₹1.22 Cr
- **EBITDA:** ₹2.78 Cr
- **52-Week High:** ₹19.44
- **52-Week Low:** ₹10.65
- **RSI (14):** 41.66

## Tapetide Score

- **Score:** 55 / 100
- **Score date:** 2026-09-04
- **Archetype:** Quality at a Reasonable Price
- **What it means:** Financial strength is not being paid for with a demanding multiple. The question worth asking is whether the quality is durable or reflects a good patch — check the consistency of returns over several years rather than the latest quarter.
- **Pillar profile:** Quality: Good · Valuation: Fair · Momentum: Flat
- **Percentile:** 70.1 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 78.7 | 9% |
| growth | 21.26 | 9% |
| momentum | 52.67 | 12% |
| ownership | 50 | 24% |
| quality | 67.25 | 22% |
| valuation | 58.88 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.99 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -2.04% over past five years.
- Company has a low return on equity of 7.22% over last 3 years.
- Debtor days have increased from 47.2 to 73.7 days.
- Working capital days have increased from 57.9 days to 89.3 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -90.52% | -82.08% | -67.8% |
| ebitda margin growth | 0% | -26.11% | -20.92% | -34.93% |
| net income growth | 0% | -44.55% | -10% | -10% |
| revenue growth | 3.7% | -18.87% | -3% | -2% |
| roce | -12.24% | 20.65% | 15.84% | 12.38% |
| roe | -25.71% | 15.64% | 7.9% | -27.64% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3.09 | 3.14 | 2.92 | 3.12 | 3.37 | 3.19 | 3.21 | 2.64 | 2.98 | 2.62 | 2.55 | 2.65 |
| Expenses | 1.96 | 2.07 | 2.01 | 2.04 | 2.21 | 2.05 | 2.5 | 2.04 | 2.21 | 1.93 | 1.84 | 1.96 |
| Operating Profit | 1.13 | 1.07 | 0.91 | 1.08 | 1.16 | 1.14 | 0.71 | 0.6 | 0.77 | 0.69 | 0.71 | 0.69 |
| OPM % | 36.57 | 34.08 | 31.16 | 34.62 | 34.42 | 35.74 | 22.12 | 22.73 | 25.84 | 26.34 | 27.84 | 26.04 |
| Other Income | 0.08 | 0.07 | 0.07 | 0.07 | 0.09 | 0.17 | 0.07 | 0.09 | 0.09 | 0.07 | 0.14 | 0.1 |
| Interest | 0.16 | 0.19 | 0.14 | 0.12 | 0.11 | 0.14 | 0.01 | 0.05 | 0.03 | 0.04 | -0.03 | 0.01 |
| Depreciation | 0.23 | 0.23 | 0.23 | 0.23 | 0.31 | 0.2 | 0.17 | 0.36 | 0.35 | 0.36 | 0.36 | 0.35 |
| Profit before tax | 0.82 | 0.72 | 0.61 | 0.8 | 0.83 | 0.97 | 0.6 | 0.28 | 0.48 | 0.36 | 0.52 | 0.43 |
| Tax % | 26.83 | 25 | 26.23 | 25 | 21.69 | 42.27 | 28.33 | 28.57 | 33.33 | 19.44 | 32.69 | 37.21 |
| Net Profit | 0.61 | 0.54 | 0.46 | 0.6 | 0.65 | 0.56 | 0.42 | 0.21 | 0.33 | 0.28 | 0.35 | 0.26 |
| EPS in Rs | 0.29 | 0.27 | 0.25 | 0.3 | 0.31 | 0.3 | 0.25 | 0.12 | 0.15 | 0.15 | 0.18 | 0.13 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 14.14 | 19.76 | 17.12 | 11.96 | 12.68 | 11.73 | 12.18 | 12.9 | 10.79 | 10.8 |
| Expenses | 8.8 | 15.58 | 13.08 | 8.24 | 7.88 | 8.03 | 8.55 | 8.8 | 8.01 | 7.94 |
| Operating Profit | 5.34 | 4.18 | 4.04 | 3.72 | 4.8 | 3.7 | 3.63 | 4.1 | 2.78 | 2.86 |
| OPM % | 37.77 | 21.15 | 23.6 | 31.1 | 37.85 | 31.54 | 29.8 | 31.78 | 25.76 | 26.48 |
| Other Income | 0.39 | 1.55 | 0.34 | 0.13 | 0.11 | 0.31 | 0.31 | 0.4 | 0.39 | 0.4 |
| Interest | 0.98 | 0.78 | 0.76 | 0.5 | 0.48 | 0.62 | 0.66 | 0.4 | 0.1 | 0.05 |
| Depreciation | 0.47 | 0.59 | 0.65 | 0.68 | 0.67 | 0.87 | 0.91 | 0.91 | 1.43 | 1.42 |
| Profit before tax | 4.28 | 4.36 | 2.97 | 2.67 | 3.76 | 2.52 | 2.37 | 3.19 | 1.64 | 1.79 |
| Tax % | 25.7 | 28.21 | 27.61 | 22.47 | 25.27 | 28.57 | 25.74 | 30.09 | 28.05 | — |
| Net Profit | 3.18 | 3.14 | 2.15 | 2.07 | 2.81 | 1.79 | 1.77 | 2.23 | 1.18 | 1.22 |
| EPS in Rs | 1.42 | 1.49 | 1.03 | 1.01 | 1.34 | 0.83 | 0.88 | 1.15 | 0.61 | 0.61 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 2.21 | 2.21 | 10.16 | 10.16 | 10.16 | 10.16 | 10.16 | 10.16 | 10.16 | 10.16 |
| Reserves | 5.86 | 7.93 | 3 | 5.09 | 7.16 | 9.9 | 11.61 | 13.41 | 15.75 | 16.99 |
| Borrowings | 6.39 | 7.64 | 6.33 | 7.19 | 4.89 | 6.99 | 6.42 | 4.8 | 1.05 | 0.25 |
| Other Liabilities | 1.07 | 1.98 | 2.78 | 2.47 | 2.36 | 2.56 | 3.04 | 2.99 | 3.35 | 2.65 |
| Total Liabilities | 15.53 | 19.76 | 22.27 | 24.91 | 24.57 | 29.61 | 31.23 | 31.36 | 30.31 | 30.05 |
| Fixed Assets | 13.6 | 15.33 | 16.97 | 17.37 | 15.04 | 15.38 | 23.42 | 23.22 | 21.16 | 21.93 |
| CWIP | 0 | 0 | 0.39 | 0.65 | 0.79 | 8.89 | 0.95 | 1.07 | 1.33 | 0 |
| Investments | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1.92 | 4.43 | 4.91 | 6.89 | 8.74 | 5.34 | 6.86 | 7.07 | 7.82 | 8.12 |
| Total Assets | 15.53 | 19.76 | 22.27 | 24.91 | 24.57 | 29.61 | 31.23 | 31.36 | 30.31 | 30.05 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2.25 | 4.49 | 3.15 | 1.16 | 1.18 | 9.21 | 2.12 | 4.01 | 0.38 | 1.72 |
| Cash from Investing Activity | -8.03 | -3.24 | -1.55 | -1.21 | 1.56 | -10.59 | -1.4 | -1.01 | 3.52 | -0.28 |
| Cash from Financing Activity | 6.43 | -0.66 | -2.09 | 0.1 | -2.8 | 1.62 | -1.2 | -2.27 | -3.87 | -1.24 |
| Net Cash Flow | 0.65 | 0.59 | -0.5 | 0.05 | -0.06 | 0.24 | -0.48 | 0.73 | 0.03 | 0.19 |
| Free Cash Flow | -8.36 | 3 | 1.58 | -0.15 | 2.68 | 0.09 | 1.19 | 3.18 | 1.26 | 1.23 |
| CFO/OP | 70 | 104 | 94 | 41 | 13 | 187 | 46 | 120 | 21 | 92 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 0 | -0.77 | 3.51 | 11.3 | 14.34 | 16.41 | 49.16 | 15.58 | 52.34 | 73.74 |
| Inventory Days | 130.36 | 220.84 | 254.58 | 179.69 | 283.89 | 185.07 | 173.44 | 232.8 | 223.53 | 297.01 |
| Days Payable | 225.95 | 226.97 | 184.03 | 151.62 | 190.61 | 100.25 | 139.79 | 63.23 | 84.88 | 85.88 |
| Cash Conversion Cycle | -95.6 | -6.91 | 74.06 | 39.38 | 107.62 | 101.23 | 82.82 | 185.15 | 190.99 | 284.87 |
| Working Capital Days | 4.51 | -42.85 | 19.4 | 75.47 | 8.55 | 6.62 | 44.5 | 3.3 | 81.21 | 89.3 |
| ROCE % | 29.19 | 32.23 | 27.11 | 17.45 | 13.97 | 17.03 | 11.13 | 10.48 | 12.71 | 6.28 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% |
| FIIs | 0.58% | 0.58% | 0.28% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 23% | 22.83% | 22.21% | 23.49% | 23.84% | 23.65% | 23.58% | 23.6% | 23.73% | 23.72% | 23.58% | 23.49% |
| Others | 2.58% | 2.75% | 3.68% | 2.68% | 2.33% | 2.52% | 2.58% | 2.57% | 2.44% | 2.44% | 2.59% | 2.67% |
| No. of Shareholders | 2628 | 3057 | 3502 | 3776 | 4067 | 4496 | 4493 | 4552 | 4550 | 4452 | 4414 | 4395 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 5 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 13.62 | Sell |
| EMA (10) | 13.57 | Sell |
| SMA (20) | 13.57 | Sell |
| EMA (20) | 13.62 | Sell |
| SMA (50) | 13.82 | Sell |
| EMA (50) | 13.84 | Sell |
| SMA (100) | 14.43 | Sell |
| EMA (100) | 14.18 | Sell |
| SMA (200) | 14.52 | Sell |
| EMA (200) | 15.12 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 43.24 | Neutral |
| MACD (12,26,9) | -0.08 | Sell |
| Stochastic (14,3,3) | 25.22 | Neutral |
| ADX (14) | 12.34 | Neutral |
| Williams %R (14) | -83.45 | Buy |
| ATR (14) | 0.66 | High Volatility |
| ROC (12) | -2.79 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 56.72 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-04 | [Notice Of 19Th Annual General Meeting Of The Company To Be Held On 29Th September 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=812454d8-23a5-468e-9d89-8d038d0a25af.pdf) |
| 2026-09-04 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d676ce8a-d886-472c-a817-35ebbd02bfa6.pdf) |
| 2026-08-13 | [Board Meeting Outcome for Outcome Of- Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=920028c7-86d5-4bc4-b308-b49c2af9eeec.pdf) |
| 2026-08-08 | [Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015 And Closure Of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d0113be-3175-4399-9c6b-669a5f0e6e54.pdf) |
| 2026-07-19 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63951d48-82b7-4c2f-926d-92efe92ca5e5.pdf) |
| 2026-06-25 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=903c4717-d844-4c4c-9992-ba94fc822109.pdf) |
| 2026-05-30 | [Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Disclosure Pursuant To Regulation 30.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c056a01d-5a3b-4f99-826d-220fdb6186fe.pdf) |
| 2026-05-30 | [Compliances-Reg.24(A)-Annual Secretarial Compliance](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ea1def7-80bf-4d42-b795-b924df4c12c4.pdf) |
| 2026-05-20 | [Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3390a4ad-48b9-4848-b734-16a24bc483e4.pdf) |
| 2026-04-28 | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c5bf618-27f1-4bb1-9955-0c03c6fd9f89.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30 June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3e71933-a38b-4062-bc1e-be9fd7c78516.pdf) |
| 2026-05-30 | [Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year End On 31St March 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=945929d7-7ae6-41ee-9489-8d8fc542e72a.pdf) |
| 2026-02-07 | [Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 31St December 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a52f24ad-36d2-442b-b9df-af1e390ed640.pdf) |
| 2025-11-08 | [Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=011cdcb5-cabf-4c2a-9e8d-21deeb91bdb2.pdf) |
| 2025-08-14 | [Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th June 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9786d420-1635-4c81-9a1a-6ecaab51c210.pdf) |
| 2025-05-29 | [Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year Endon 31St March 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da26b089-a3ca-4c99-a3d7-6411314ee90a.pdf) |
| 2025-02-11 | [Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 31St December 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd0bdf00-e516-4773-9ef8-72972e056f7a.pdf) |
| 2024-11-14 | [Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th September 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa8118a3-5ef2-4727-8ac4-f863af8aa55d.pdf) |
| 2024-08-14 | [Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th June 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cd7c906-454e-414b-8a4b-402c933077c4.pdf) |
| 2024-05-28 | [Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year End On 31Th March, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=815a5772-7b39-4545-969a-070821b6be10.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Tejnaksh Healthcare says share price movement is market-driven and no undisclosed material information exists. | [Reply To The Clarification Sought By The Stock Exchange With Reference To The Significant Movement In Share Price Of The Securities Of The Company; 9 Apr - Tejnaksh Healthcare says share price movement is market-driven and no undisclosed material information exists.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a7f1bf16-4f42-4633-98ba-9f1db364dc72.pdf) |
| 7 Feb - Approved unaudited standalone and consolidated results for quarter/nine months ended 31 Dec 2025; limited review clean. | [Board Meeting Outcome for Outcome Of Board Meeting In_Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Held On 7Th Feb 2026 7 Feb - Approved unaudited standalone and consolidated results for quarter/nine months ended 31 Dec 2025; limited review clean.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/45668e3d-6eb6-45e9-ab0f-fec790823424.pdf) |
| 4h - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 4h - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/10a14bca-68e7-494f-9544-fa093a53c19b.pdf) |
| 28 Dec 2025 - Trading window closed from 01-Jan-2026 until 48 hours after results for quarter/year ending 31-Dec-2025. | [Closure of Trading Window 28 Dec 2025 - Trading window closed from 01-Jan-2026 until 48 hours after results for quarter/year ending 31-Dec-2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3aaa3d26-47a8-4fa7-8f3d-dda57015fbd7.pdf) |
| 28 Apr - Tejnaksh Healthcare confirms it is not a Large Corporate; outstanding borrowing nil as of March 31. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 28 Apr - Tejnaksh Healthcare confirms it is not a Large Corporate; outstanding borrowing nil as of March 31.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6c5bf618-27f1-4bb1-9955-0c03c6fd9f89.pdf) |
| 28 Apr - Tejnaksh Healthcare confirms it is not a Large Corporate; outstanding borrowing nil as of March 31. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 28 Apr - Tejnaksh Healthcare confirms it is not a Large Corporate; outstanding borrowing nil as of March 31.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/6c5bf618-27f1-4bb1-9955-0c03c6fd9f89.pdf) |
| 27 Mar - Trading window closed Apr 1, 2026 until 48 hours after Q4/FY2026 results. | [Closure of Trading Window 27 Mar - Trading window closed Apr 1, 2026 until 48 hours after Q4/FY2026 results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a42d3083-3e95-4675-8d0e-03be2527467b.pdf) |
| 22 January 2026 - Mr. Pranav Kailas Bagal appointed CFO effective January 22, 2026; holds 44.33% shares; ~7 years experience. | [Appointment 22 January 2026 - Mr. Pranav Kailas Bagal appointed CFO effective January 22, 2026; holds 44.33% shares; ~7 years experience.](https://nsearchives.nseindia.com/corporate/NIRMANAGRI_22012026174150_Intimation_Regulation_CFO_NAGL_220126_Signed.pdf) |
| 22 January 2026 - Appointed Pranav Kailas Bagal as CFO effective 22 Jan 2026; holds 44.33% shareholding. | [Outcome of Board Meeting 22 January 2026 - Appointed Pranav Kailas Bagal as CFO effective 22 Jan 2026; holds 44.33% shareholding.](https://nsearchives.nseindia.com/corporate/NIRMANAGRI_22012026173932_Outcome_of_Board_Meeting_CFO_NAGL_220126_Signed.pdf) |
| 21 January 2026 - SDD compliance certificate for quarter ended 31 Dec 2025; four UPSI events captured. | [Structural Digital Database 21 January 2026 - SDD compliance certificate for quarter ended 31 Dec 2025; four UPSI events captured.](https://nsearchives.nseindia.com/corporate/NIRMANAGRI_21012026161839_SDD_Nirman.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2023 | [Concall - Oct 2023](https://nsearchives.nseindia.com/corporate/NIRMAN_18102023145115_181023NAGLInvestorPresentation.pdf) |
| May 2023 | [Concall - May 2023](https://archives.nseindia.com/corporate/NIRMAN_30052023143329_300523NAGLInvestorPresentation.pdf) |
| Mar 2025 | [Concall - Mar 2025](https://nsearchives.nseindia.com/corporate/NIRMANAGRI_03032025132726_030325NAGLEarningCall.pdf) |
| Jul 2024 | [Concall - Jul 2024](https://nsearchives.nseindia.com/corporate/NIRMAN_01072024125454_130423NAGLInvestorPresentation.pdf) |
| Jul 2024 | [Concall - Jul 2024](https://nsearchives.nseindia.com/corporate/NIRMAN_01072024105553_130423NAGLInvestorPresentation.pdf) |
| Jul 2023 | [Concall - Jul 2023](https://archives.nseindia.com/corporate/NIRMAN_20072023153412_200723_NAGL_InvestorPresentation.pdf) |
| Feb 2018 | [Concall - Feb 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4966a057-cd01-4235-911e-0df3d736d971.pdf) |
| Feb 2018 | [Concall - Feb 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/2/4966a057-cd01-4235-911e-0df3d736d971.pdf) |
| Apr 2023 | [Concall - Apr 2023](https://archives.nseindia.com/corporate/NIRMAN_13042023112739_130423NAGLInvestorPresentation.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_29006_NIRMAN_2024_2025_A_4109362_09092025192315.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26263_NIRMAN_2023_2024_26092024183123.pdf) |
| from nse | [Financial Year 2023 from nse](https://archives.nseindia.com/annual_reports/SME_AR_23900_NIRMAN_2022_2023_11092023150520_09112023160001.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/96222a73-0c9a-4751-a18e-ea914d5c3b94.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e98f4fb2-c6d0-427f-a4af-92d4c8597074.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7408035d-bdd9-4bd4-aece-8f0dfd7292f7.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/539428/75472539428.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/539428/70666539428.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/539428/66375539428.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/539428/5394280319.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:44:33.037Z.